XML 16 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Schedule I (PARENT COMPANY ONLY) (CONDENSED STATEMENTS OF CASH FLOWS) (Details) - Parent Company [Member] - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 01, 2013
Feb. 28, 2013
Nov. 30, 2013
Nov. 30, 2015
Nov. 30, 2014
Leucadia [Member]          
Cash paid (received) during the period for:          
Redeemable preferred interests $ 362,300        
Successor [Member]          
Cash flows from operating activities:          
Net earnings     $ 161,191 $ 93,534 $ 157,560
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:          
Amortization     (62,305) (76,945) (80,424)
Undistributed earnings of subsidiaries     (153,751) (71,739) (125,450)
Income on loans to and investments in related parties     (58,197) (40,460) (67,965)
Distributions received on investments in related parties     0 40,500 35,562
Other adjustments     (15,471) (98,870) (78,064)
Net change in assets and liabilities:          
Cash and securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations     (7,151) (4,714) (28,155)
Financial instruments owned     76,724 53,290 (45,950)
Loans to and investments in related parties     0 0 0
Investments in managed funds     3,230 19,907 (1,028)
Other assets     108,877 77,064 47,666
Financial instruments sold, not yet purchased     107 (8,802) 21,462
Accrued expenses and other liabilities     (52,944) (36,397) 38,477
Net cash (used in) provided by operating activities     310 (53,632) (126,309)
Cash flows from investing activities:          
Investments in, advances to and subordinated notes receivable from subsidiaries     (74,742) 420,797 82,143
Loans to and investments in related parties     128,638 (19,301) (469)
Cash received from contingent consideration     3,796 4,444 6,253
Net cash provided by (used in) investing activities     57,692 405,940 87,927
Cash flows from financing activities:          
Excess tax benefits from the issuance of share-based awards     3,054 749 1,921
Proceeds from short-term borrowings     0 750,000 1,160,000
Payments on short-term borrowings     0 (750,000) (1,160,000)
Net proceeds from issuance of senior notes, net of issuance costs     0 0 681,222
Repayment of long-term debt     0 (500,000) (250,000)
Payments on repurchase of common stock     0 0 0
Payments on dividends     0 0 0
Proceeds from exercise of stock options, not including tax benefits     0 0 0
Net cash (used in) provided by financing activities     3,054 (499,251) 433,143
Net (decrease) increase in cash and cash equivalents     61,056 (146,943) 394,761
Cash and cash equivalents at beginning of period 515,365   515,365 971,182 576,421
Cash and cash equivalents at end of period   $ 515,365 576,421 824,239 971,182
Cash paid (received) during the period for:          
Interest     238,817 329,926 330,261
Income taxes, net     56,130 $ (5,859) $ 111,542
Predecessor [Member]          
Cash flows from operating activities:          
Net earnings   80,138      
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:          
Amortization   3,666      
Undistributed earnings of subsidiaries   (89,318)      
Income on loans to and investments in related parties   0      
Distributions received on investments in related parties   0      
Other adjustments   22,350      
Net change in assets and liabilities:          
Cash and securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations   (5,000)      
Financial instruments owned   (63,244)      
Loans to and investments in related parties   (111,022)      
Investments in managed funds   (2,300)      
Other assets   (1,544)      
Financial instruments sold, not yet purchased   1,054      
Accrued expenses and other liabilities   5,529      
Net cash (used in) provided by operating activities   (159,691)      
Cash flows from investing activities:          
Investments in, advances to and subordinated notes receivable from subsidiaries   (235,097)      
Loans to and investments in related parties   0      
Cash received from contingent consideration   1,203      
Net cash provided by (used in) investing activities   (233,894)      
Cash flows from financing activities:          
Excess tax benefits from the issuance of share-based awards   5,682      
Proceeds from short-term borrowings   0      
Payments on short-term borrowings   0      
Net proceeds from issuance of senior notes, net of issuance costs   991,469      
Repayment of long-term debt   0      
Payments on repurchase of common stock   (166,541)      
Payments on dividends   (15,799)      
Proceeds from exercise of stock options, not including tax benefits   57      
Net cash (used in) provided by financing activities   814,868      
Net (decrease) increase in cash and cash equivalents   421,283      
Cash and cash equivalents at beginning of period $ 515,365 94,082 $ 515,365    
Cash and cash equivalents at end of period   515,365      
Cash paid (received) during the period for:          
Interest   70,385      
Income taxes, net   $ (33,103)